Cell line · CVCL_1401
ME-180
Cancer cell line, Homo sapiens. Human papillomavirus-related cervical squamous cell carcinoma. 42 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. ME-180. Cell lines, record CVCL_1401. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1401
On this page
Cell line
As Cellosaurus gives it.
- Name
- ME-180
- Accession
- CVCL_1401
- RRID
- RRID:CVCL_1401
- Synonyms
- Me-180, ME 180, ME180
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 66Y
- Category
- Cancer cell line
- Diseases
- Human papillomavirus-related cervical squamous cell carcinoma (NCIt C27676); Squamous cell carcinoma of the cervix uteri (ORDO Orphanet_213767)
- Derived from
- Omentum (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers42
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Dual Inhibition of TRIP13 and Aurora A Induces Mitotic DNA Damage and Concurrent Pyroptotic-Apoptotic Cell Death in Rb-Deficient Cancer Cells. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy. | Neoplasia | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy. | medRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Calmodulin-Like Protein 5 (CALML5) Expression in Squamous Cell Carcinoma of Esophagus and Oropharynx. | Acta Histochem Cytochem | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeting HSP70-E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical Cancer. | J Med Virol | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma. | EBioMedicine | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Distinct mechanism of cervical cancer cell death caused by the investigational new drug SHetA2. | Front Oncol | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments. | Pharmaceutics | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells. | Front Oncol | 2021 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 42
See all 42 papersRelatives9
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | CellSensor AP1-bla ME-180 | CVCL_KS60 | Cell lines | |
| Derived from it | CellSensor GAS-bla ME-180 | CVCL_KS52 | Cell lines | |
| Derived from it | CellSensor HRE-bla ME-180 | CVCL_KS07 | Cell lines | |
| Derived from it | CellSensor NFkB-bla ME-180 | CVCL_KB44 | Cell lines | |
| Derived from it | CellSensor SIE-bla ME-180 | CVCL_KS28 | Cell lines | |
| Derived from it | CellSensor c-fos-bla ME-180 | CVCL_KS68 | Cell lines | |
| Derived from it | OV-2008 | CVCL_0473 | Has a recorded problem | Cell lines |
| Derived from it | SF767 | CVCL_6950 | Has a recorded problem | Cell lines |
| Derived from it | TSGH-8301 | CVCL_A342 | Has a recorded problem | Cell lines |
Cell banks8
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-7932 | Discontinued | Cellosaurus |
| ATCC | HTB-33 | ATCC | |
| CLS | 300196 | CLS | |
| ICLC | HTL96027 | ICLC | |
| JCRB | JCRB0810 | JCRB | |
| KCLB | 30033 | KCLB | |
| RCB | RCB2106 | RCB | |
| TKG | TKG 0437 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1401
GET https://conductscience.org/api/cell-lines/v1/CVCL_1401/papers?page=2